Ironwood Pharmaceuticals Inc (IRWD)
8.10
-0.21
(-2.53%)
USD |
NASDAQ |
Apr 24, 16:00
8.20
+0.10
(+1.23%)
Pre-Market: 09:22
Ironwood Pharmaceuticals Research and Development Expense (Quarterly): 35.68M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 35.68M |
| September 30, 2023 | 32.98M |
| June 30, 2023 | 34.58M |
| March 31, 2023 | 12.85M |
| December 31, 2022 | 10.45M |
| September 30, 2022 | 11.54M |
| June 30, 2022 | 11.45M |
| March 31, 2022 | 10.82M |
| December 31, 2021 | 31.85M |
| September 30, 2021 | 10.91M |
| June 30, 2021 | 12.16M |
| March 31, 2021 | 15.48M |
| December 31, 2020 | 16.27M |
| September 30, 2020 | 21.69M |
| June 30, 2020 | 22.08M |
| March 31, 2020 | 28.03M |
| December 31, 2019 | 26.54M |
| September 30, 2019 | 27.55M |
| June 30, 2019 | 28.76M |
| March 31, 2019 | 32.20M |
| December 31, 2018 | 28.24M |
| September 30, 2018 | 29.16M |
| June 30, 2018 | 23.19M |
| March 31, 2018 | 36.50M |
| December 31, 2017 | -19.97M |
| Date | Value |
|---|---|
| September 30, 2017 | 37.06M |
| June 30, 2017 | 37.34M |
| March 31, 2017 | 33.70M |
| December 31, 2016 | 38.44M |
| September 30, 2016 | 37.53M |
| June 30, 2016 | 31.68M |
| March 31, 2016 | 31.84M |
| December 31, 2015 | 27.63M |
| September 30, 2015 | 25.83M |
| June 30, 2015 | 28.65M |
| March 31, 2015 | 26.64M |
| December 31, 2014 | 27.48M |
| September 30, 2014 | 25.12M |
| June 30, 2014 | 22.14M |
| March 31, 2014 | 27.14M |
| December 31, 2013 | 22.52M |
| September 30, 2013 | 23.02M |
| June 30, 2013 | 24.09M |
| March 31, 2013 | 32.75M |
| December 31, 2012 | 28.27M |
| September 30, 2012 | 23.45M |
| June 30, 2012 | 32.24M |
| March 31, 2012 | 29.51M |
| December 31, 2011 | 24.22M |
| September 30, 2011 | 22.90M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
10.45M
Minimum
Dec 2022
35.68M
Maximum
Dec 2023
21.14M
Average
21.69M
Median
Sep 2020
Research and Development Expense (Quarterly) Benchmarks
| Societal CDMO Inc (DELISTED) | -- |
| OPKO Health Inc | 19.39M |
| Inari Medical Inc | 22.89M |
| Kineta Inc | 1.561M |
| Moderna Inc | 1.406B |